Activest Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Activest Wealth Management's CRL Position: Q3 2026 in Review
Activest Wealth Management reduced its Charles River Laboratories (CRL) stake by 25% in Q3 2026, selling an estimated $14.5K and leaving 165 shares worth $48.7K. The position accounts for 0.01% of the portfolio, ranked #277.
Activest Wealth Management first reported a position in CRL in Q1 2025 and has held it in 7 quarters since. The position peaked at $49.9K in Q2 2026. 644 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Activest Wealth Management held 165 shares of Charles River Laboratories worth $48.7K as of Q3 2026.
- Activest Wealth Management sold 55 Charles River Laboratories shares in Q3 2026, an estimated $14.5K.
- Charles River Laboratories made up 0.01% of Activest Wealth Management's portfolio in Q3 2026, its #277 holding.
- Activest Wealth Management first reported a position in Charles River Laboratories in Q1 2025 and has held it in 7 quarters since.
- Activest Wealth Management's Charles River Laboratories position peaked at $49.9K in Q2 2026.
- 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.